http://orcid.org/0000-0003-4274-9258
Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yitian Lang, Bin Wu, Zhilin Sun, Erjia Ye, Guanshen Dou & Xin Guan. (2022) Patient Preference for Biologic Treatments of Psoriasis in the Chinese Setting. Patient Preference and Adherence 16, pages 1071-1084.
Read now
Read now
Steven R. Feldman, Christine Poulos, Isabelle Gilloteau, Brennan Mange, Katharina Boehm, Marco Boeri, Mandy Naatz & Matthias Augustin. (2022) Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany. Journal of Dermatological Treatment 33:3, pages 1511-1520.
Read now
Read now
Articles from other publishers (14)
Ilse van Ee, Elfie Deprez, Alexander Egeberg, Curdin Conrad, Valeria Corazza, Ludovica Donati, Jo Lambert, Rozalina Lăpădatu, Anette Meyer, Carle Paul, Rebecca Penzer‐Hick, Karen Stephen, Jim van der Zon & Anthony Bewley. (2023) Freedom from disease in plaque psoriasis: Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nurses. Journal of the European Academy of Dermatology and Venereology 38:1.
Crossref
Crossref
Linh K. Vo, Michelle J. Allen, Michelle Cunich, Janani Thillainadesan, Steven M. McPhail, Pakhi Sharma, Shannon Wallis, Kelly McGowan & Hannah E. Carter. (2024) Stakeholders’ preferences for the design and delivery of virtual care services: A systematic review of discrete choice experiments. Social Science & Medicine 340, pages 116459.
Crossref
Crossref
Bruce Strober, Laura C. Coates, Mark G. Lebwohl, Atul Deodhar, Evan Leibowitz, Katelyn Rowland, Alexa P. Kollmeier, Megan Miller, Yanli Wang, Shu Li, Soumya D. Chakravarty, Daphne Chan, May Shawi, Ya-Wen Yang, Diamant Thaҫi & Proton Rahman. (2023) Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis. Drug Safety 47:1, pages 39-57.
Crossref
Crossref
Yihua Li, Lauren K W Lau, Kuan Peng, Dexing Zhang, Dong Dong, Ian C K Wong & Xue Li. (2023) Factors influencing choice of b/ts DMARDs in managing inflammatory arthritis from a patient perspective: a systematic review of global evidence and a patient-based survey from Hong Kong. BMJ Open 13:10, pages e069681.
Crossref
Crossref
Mark G Lebwohl, Joseph F Merola, Katelyn Rowland, Megan Miller, Ya-Wen Yang, Jenny Yu, Yin You, Daphne Chan, Diamant Thaçi & Richard G Langley. (2023) Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure. British Journal of Dermatology 189:1, pages 42-52.
Crossref
Crossref
Diamant Thaçi, Stefano Piaserico, Kristian Gaarn Du Jardin & Richard B. Warren. (2022)
Long‐term stability of
PASI
<3 response to tildrakizumab: Pooled analyses from
reSURFACE
1 and
reSURFACE
2 phase 3 trials through 5 years
. Journal of the European Academy of Dermatology and Venereology 37:4.
Crossref
Crossref
Sinaa Al-Aqeel, Reem Alotaiwi & Bushra Albugami. (2023) Patient preferences for epilepsy treatment: a systematic review of discrete choice experimental studies. Health Economics Review 13:1.
Crossref
Crossref
Damon Willems, Eva-Lotta Hinzpeter, Hessel H. Van der Zee, Christopher J. Sayed, John R. Ingram, Charlotte Beaudart, Silvia M. A. A. Evers & Mickael Hiligsmann. (2023) Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The Patient - Patient-Centered Outcomes Research 16:2, pages 153-164.
Crossref
Crossref
Daksh Choudhary, Megan Thomas, Kevin Pacheco-Barrios, Yuan Zhang, Pablo Alonso-Coello, Holger Schünemann & Glen Hazlewood. (2022) Methods to Summarize Discrete-Choice Experiments in a Systematic Review: A Scoping Review. The Patient - Patient-Centered Outcomes Research 15:6, pages 629-639.
Crossref
Crossref
Ilene L. Hollin, Jonathan Paskett, Anne L. R. Schuster, Norah L. Crossnohere & John F. P. Bridges. (2022) Best–Worst Scaling and the Prioritization of Objects in Health: A Systematic Review. PharmacoEconomics 40:9, pages 883-899.
Crossref
Crossref
Damon Willems, Mickael Hiligsmann, Hessel H van der Zee, Christopher J Sayed & Silvia M A A Evers. (2021) Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study. The Patient - Patient-Centered Outcomes Research 15:2, pages 207-218.
Crossref
Crossref
April W. Armstrong, Ahmed M. Soliman, Keith A. Betts, Yan Wang, Yawen Gao, Vassilis Stakias & Luis Puig. (2021) Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. Dermatology and Therapy 12:1, pages 167-184.
Crossref
Crossref
Marilyn Emma Diks, Mickael Hiligsmann & Ingeborg Maria van der Putten. (2021) Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments. BMC Infectious Diseases 21:1.
Crossref
Crossref
Ulrich Mrowietz. (2021) Management der Psoriasis. hautnah dermatologie 37:S1, pages 6-13.
Crossref
Crossref